+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Immunotherapy Drugs - Market Analysis, Trends, and Forecasts

  • ID: 4805503
  • Report
  • 94 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbvie
  • Astrazeneca Plc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • MORE
The Immunotherapy Drugs market worldwide is projected to grow by US$198 Billion, driven by a compounded growth of 13.7%. Cancer, one of the segments analyzed and sized in this study, displays the potential to grow at over 14.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$175.9 Billion by the year 2025, Cancer will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 14.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$7.7 Billion to the region's size and clout in the next 5 to 6 years. Over US$9.5 Billion worth of projected demand in the region will come from the rest of the European markets. In Japan, Cancer will reach a market size of US$13.6 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.5% over the next couple of years and add approximately US$34.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • AbbVie, Inc.
  • Amgen, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International AG
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbvie
  • Astrazeneca Plc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Immunotherapy Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Immunotherapy Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Immunotherapy Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Immunotherapy Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Cancer (Therapy Area) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Cancer (Therapy Area) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Cancer (Therapy Area) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Autoimmune & Inflammatory Diseases (Therapy Area) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Autoimmune & Inflammatory Diseases (Therapy Area) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Autoimmune & Inflammatory Diseases (Therapy Area) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Infectious Diseases (Therapy Area) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Infectious Diseases (Therapy Area) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Infectious Diseases (Therapy Area) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Other Therapy Areas (Therapy Area) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Other Therapy Areas (Therapy Area) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Other Therapy Areas (Therapy Area) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Immunotherapy Drugs Market Share (in %) by Company: 2019 & 2025

TABLE 16: United States Immunotherapy Drugs Market Estimates and Projections in US$ Million by Therapy Area: 2018 to 2025

TABLE 17: Immunotherapy Drugs Market in the United States by Therapy Area: A Historic Review in US$ Million for 2009-2017

TABLE 18: United States Immunotherapy Drugs Market Share Breakdown by Therapy Area: 2009 VS 2019 VS 2025

CANADA

TABLE 19: Canadian Immunotherapy Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2018 to 2025

TABLE 20: Canadian Immunotherapy Drugs Historic Market Review by Therapy Area in US$ Million: 2009-2017

TABLE 21: Immunotherapy Drugs Market in Canada: Percentage Share Breakdown of Sales by Therapy Area for 2009, 2019, and 2025

JAPAN

TABLE 22: Japanese Market for Immunotherapy Drugs: Annual Sales Estimates and Projections in US$ Million by Therapy Area for the Period 2018-2025

TABLE 23: Immunotherapy Drugs Market in Japan: Historic Sales Analysis in US$ Million by Therapy Area for the Period 2009-2017

TABLE 24: Japanese Immunotherapy Drugs Market Share Analysis by Therapy Area: 2009 VS 2019 VS 2025

CHINA

TABLE 25: Chinese Immunotherapy Drugs Market Growth Prospects in US$ Million by Therapy Area for the Period 2018-2025

TABLE 26: Immunotherapy Drugs Historic Market Analysis in China in US$ Million by Therapy Area: 2009-2017

TABLE 27: Chinese Immunotherapy Drugs Market by Therapy Area: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Immunotherapy Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 28: European Immunotherapy Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 29: Immunotherapy Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 30: European Immunotherapy Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 31: European Immunotherapy Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2018-2025

TABLE 32: Immunotherapy Drugs Market in Europe in US$ Million by Therapy Area: A Historic Review for the Period 2009-2017

TABLE 33: European Immunotherapy Drugs Market Share Breakdown by Therapy Area: 2009 VS 2019 VS 2025

FRANCE

TABLE 34: Immunotherapy Drugs Market in France by Therapy Area: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 35: French Immunotherapy Drugs Historic Market Scenario in US$ Million by Therapy Area: 2009-2017

TABLE 36: French Immunotherapy Drugs Market Share Analysis by Therapy Area: 2009 VS 2019 VS 2025

GERMANY

TABLE 37: Immunotherapy Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy Area for the Period 2018-2025

TABLE 38: German Immunotherapy Drugs Historic Market Analysis in US$ Million by Therapy Area: 2009-2017

TABLE 39: German Immunotherapy Drugs Market Share Breakdown by Therapy Area: 2009 VS 2019 VS 2025

ITALY

TABLE 40: Italian Immunotherapy Drugs Market Growth Prospects in US$ Million by Therapy Area for the Period 2018-2025

TABLE 41: Immunotherapy Drugs Historic Market Analysis in Italy in US$ Million by Therapy Area: 2009-2017

TABLE 42: Italian Immunotherapy Drugs Market by Therapy Area: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 43: United Kingdom Market for Immunotherapy Drugs: Annual Sales Estimates and Projections in US$ Million by Therapy Area for the Period 2018-2025

TABLE 44: Immunotherapy Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy Area for the Period 2009-2017

TABLE 45: United Kingdom Immunotherapy Drugs Market Share Analysis by Therapy Area: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 46: Rest of Europe Immunotherapy Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2018-2025

TABLE 47: Immunotherapy Drugs Market in Rest of Europe in US$ Million by Therapy Area: A Historic Review for the Period 2009-2017

TABLE 48: Rest of Europe Immunotherapy Drugs Market Share Breakdown by Therapy Area: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 49: Immunotherapy Drugs Market in Asia-Pacific by Therapy Area: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 50: Asia-Pacific Immunotherapy Drugs Historic Market Scenario in US$ Million by Therapy Area: 2009-2017

TABLE 51: Asia-Pacific Immunotherapy Drugs Market Share Analysis by Therapy Area: 2009 VS 2019 VS 2025

REST OF WORLD

TABLE 52: Rest of World Immunotherapy Drugs Market Estimates and Forecasts in US$ Million by Therapy Area: 2018 to 2025

TABLE 53: Rest of World Immunotherapy Drugs Historic Market Review by Therapy Area in US$ Million: 2009-2017

TABLE 54: Immunotherapy Drugs Market in Rest of World: Percentage Share Breakdown of Sales by Therapy Area for 2009, 2019, and 2025

IV. COMPETITION

ABBVIE

ASTRAZENECA PLC

BRISTOL-MYERS SQUIBB COMPANY

ELI LILLY AND COMPANY

F. HOFFMANN-LA ROCHE AG

GLAXOSMITHKLINE PLC

JOHNSON & JOHNSON

MERCK & CO.

NOVARTIS INTERNATIONAL AG

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbvie
  • Astrazeneca Plc
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Merck & Co.
  • Novartis International Ag
Note: Product cover images may vary from those shown
Adroll
adroll